Announcements Trials
Browse Landscape

Phase

Phase 2 78Phase 1/2 24Phase 3 23Phase NA 5Phase 1 4Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1

Status

Unknown 5Recruiting 5Not yet recruiting 3

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 2Breast 1

Conditions

Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Rectal Neoplasms 1Gestational Trophoblastic Disease 1Cholangiocarcinoma 1

Interventions

Blood Specimen Collection 104Standard of Care 79Exercise 67Radiotherapy 53Radiosurgery 48Specimen Handling 45Magnetic Resonance Spectroscopy 45Surveys and Questionnaires 44Interviews as Topic 44Practice Guidelines as Topic 43Educational Status 43Methods 41Drug Therapy 35Early Intervention, Educational 30Surgical Procedures, Operative 29Palliative Care 25Control Groups 25Biopsy 24Patient Navigation 18venetoclax 17Cisplatin 17Therapeutics 16Resistance Training 16Proton Therapy 15Magnetic Resonance Imaging 15Behavior Therapy 15Neoadjuvant Therapy 13Cognitive Behavioral Therapy 13Acupuncture Therapy 13Nutritional Status 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase NA × Recruiting × toripalimab × Clear all
NCT06371274 2025-08-12

A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.

First Affiliated Hospital of Zhejiang University

Phase NA Recruiting
29 enrolled
Breast

Triple Negative Breast Neoplasms

NCT06028672 2025-02-06

TA56

Peking Union Medical College Hospital

Phase NA Recruiting
40 enrolled
Gynecologic

Gestational Trophoblastic Disease

NCT05215665 2024-12-11

GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma

Tianjin Medical University Cancer Institute and Hospital

Phase NA Recruiting
146 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT06256224 2024-04-24

Toripalimab Combined With Definitive CCRT for LACC Patients

Ruijin Hospital

Phase NA Recruiting
150 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT05877573 2023-07-05

Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced,High-Risk,MSS Rectal Cancer

Nanfang Hospital, Southern Medical University

Phase NA Recruiting
53 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡